Evidence map›Paper›PMID 31275351›Full record

ArticleFrontiers in genetics2019

RNA-Seq Revealed Novel Non-proliferative Retinopathy Specific Circulating MiRNAs in T2DM Patients.

Zimeng Li, Ying Dong, Chang He, Xingchen Pan, Dianyuan Liu, Jianli Yang, Liankun Sun, Peng Chen, Qing Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Zimeng LiDepartment of Endocrinology, China-Japan Union Hospital, Jilin University, Changchun, China.
Ying DongDepartment of Radiotherapy, The Tumor Hospital of Jilin Province, Changchun, China.
Chang HeDepartment of Genetics, College of Basic Medical Sciences, Jilin University, Changchun, China.
Xingchen PanDepartment of Genetics, College of Basic Medical Sciences, Jilin University, Changchun, China.
Dianyuan LiuDepartment of Endocrinology, China-Japan Union Hospital, Jilin University, Changchun, China.
Jianli YangDepartment of Genetics, College of Basic Medical Sciences, Jilin University, Changchun, China.
Liankun SunDepartment of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, China.
Peng ChenDepartment of Genetics, College of Basic Medical Sciences, Jilin University, Changchun, China.
Qing WangDepartment of Endocrinology, China-Japan Union Hospital, Jilin University, Changchun, China.
Jilin University · CNUnion Hospital · CNJilin Medical University · CNJilin Province Tumor Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diabetes retinopathyearly predictionmicroRNApolygenic risk scoretype 2 diabete mellitus

Identifiers

PMID31275351
PMCPMC6593299
OpenAlexW2948231142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.